Ryan Rauch
Ryan Rauch
buyers current extremely impressed posted quarter results solid stock
We were extremely impressed by the solid results posted in the first quarter and would be buyers of the stock at current levels.
believed chance good months people six
Six months ago, people believed there was good chance he (Tobin) would leave.
huge supporting
We're supporting it because it's a huge opportunity.
believe boston risks scientific
There are some significant risks for Boston Scientific from an integration standpoint, but I believe the combination of Boston Scientific and Guidant makes a lot of sense.
device medical missed small tape
They missed the (forecast) by $1 million, and it's a very choppy tape for small medical device companies.
believe boston buys covers device legitimate player stand time ultimately underneath wants
Underneath the covers I believe that Abbott wants to be a device player and for the first time they are making a real legitimate stand to become one. If Boston doesn't get Guidant, at this valuation, I think Abbott ultimately buys Boston.
clearly closed deal stage
Clearly it is a positive. It should set the stage for the deal to be closed in September.
issues
They have really alleviated the issues about an antitrust review.
buy friendly lead saying
I'm not saying Abbott is going to buy them tomorrow, but I think it's the first friendly overture that could lead to a long relationship.
board boston felt loyalty offers scientific understood
I've been a little perplexed. I've always felt that Boston Scientific offers have been superior. I've not understood the loyalty of Guidant's board to J&J.